Breaking News Instant updates and real-time market news.

PCRX

Pacira

$33.30

3.8 (12.88%)

, HRTX

Heron Therapeutics

$26.75

-1.15 (-4.12%)

06:05
04/09/18
04/09
06:05
04/09/18
06:05

Piper reiterates Overweight on Pacira after 'watershed' nerve block approval

FDA approval of Pacira Pharmaceuticals' (PCRX) Exparel as a brachial plexus block "is something of a watershed" in that the agency has never before approved any local or regional anesthetic for a single, specific setting, Piper Jaffray analyst David Amsellem tells investors in a research note. He believes the approval suggests an increasingly aggressive FDA approach towards the opioid crisis. Amsellem points out, however, that feedback from his surgeon survey suggests a "strong degree of enthusiasm" for Heron Therapeutics' (HTRX) HTX-011. However, the feedback also indicates that non-opioid, post-operative pain space is not a zero-sum game, the analyst writes. He believes Exparel can grow "even amid greater competition." Amsellem reiterates an Overweight rating on Pacira with a $44 price target.

PCRX

Pacira

$33.30

3.8 (12.88%)

HRTX

Heron Therapeutics

$26.75

-1.15 (-4.12%)

  • 16

    Apr

  • 08

    May

PCRX Pacira
$33.30

3.8 (12.88%)

03/19/18
JEFF
03/19/18
NO CHANGE
Target $30
JEFF
Buy
Heron pain drug 'hits a home run' in Phase III studies, says Jefferies
Jefferies analyst Biren Amin says Heron Therapeutics's (HRTX) HTX-011 "hits a home run" by meeting all primary and key secondary endpoints this morning from Phase III trials in bunionectomy and hernia repair. Safety looked clean in both studies, and HTX-011 produced durable pain reduction up to 72 hours and significant opioid sparing effect and differentiates from generic bupivacaine, Amin tells investors in a research note. The analyst believes HTX-011 should receive a superiority claim versus generic bupivacaine in its label for both bunionectomy and hernia surgery. Amin notes that Pacira's (PCRX) Exparel does not have this claim in its label. He assumes peak sales of $545M for HTX-011 and keeps a Buy rating on Heron with $30 price target.
03/20/18
GHSC
03/20/18
NO CHANGE
Target $42
GHSC
Buy
Pacira price target lowered to $42 after Heron data at Seaport Global
Seaport Global analyst Corey Davis noted that Heron Therapeutics (HRTX) reported positive results from its two Phase 3 studies of HTX-011 for postoperative pain in bunionectomy and herniorrhaphy. While Heron's HTX-011 data suggest some competition in 2020 for Pacira's (PCRX) Exparel, Davis said dose and volume "present problems" and that Heron "may run into a pricing problem" as well. He reiterates his Buy rating on Pacira shares, though he lowered his price target on the stock to $42 from $50, noting that he has formally removed nerve block revenue for Exparel entirely from his model after the negative FDA AdCom last month.
03/21/18
JEFF
03/21/18
NO CHANGE
Target $49
JEFF
Buy
Pacira shares could be positioned for rebound, says Jefferies
Jefferies analyst David Steinberg believes shares of Pacira Pharmaceuticals could be positioned for a rebound after Symphony Health data indicated Exparel posted "well above trend growth" in February. Sales were $24M, up 3.4% from last month and up 12.6% year-over-year, according to Symphony. The data have shown double digit year-over-years gains in four of the past five months, versus just one of nine months prior, Steinberg tells investors in a research note. He believes Pacira is attractively valued at current levels and keeps a Buy rating on the shares with a $49 price target.
04/06/18
WEDB
04/06/18
NO CHANGE
Target $72
WEDB
Outperform
Wedbush says FDA response for Pacira's EXPAREL in nerve block due
Wedbush analyst Liana Moussatos reiterated an Outperform rating and $72 price target on Pacira Pharmaeuticals ahead of the expected PDUFA date for potential expansion of EXPAREL's label to specify nerve block. In a research note to investors, the analyst said she is "hopeful" that EXPAREL could potentially be used to provide improved outcomes in long-acting regional analgesia compared to infusion pumps or opioids. Whether required post-approval or in preparation for future regulatory review, she sees Pacira to continuing to evaluate EXPAREL in different nerve block techniques.
HRTX Heron Therapeutics
$26.75

-1.15 (-4.12%)

03/20/18
NEED
03/20/18
NO CHANGE
Target $42
NEED
Buy
Heron Therapeutics price target raised to $42 from $30 at Needham
Needham analyst Serge Belanger raised his price target on Heron Therapeutics to $42 after the company's phase 3 trial results for HTX-011 on post-surgical pain management. The analyst says the treatment met all the primary and secondary endpoints while also demonstrating superiority over placebo and bupivacaine in terms of pain relief and opioid consumption. Belanger keeps his Buy rating on Heron Therapeutics, adding that the HTX-011 could be "game changer", with NDA filing coming in the second half of this year.
04/05/18
LSCM
04/05/18
NO CHANGE
Target $42
LSCM
Buy
Heron 'ready for liftoff' after secondary offering, says Lake Street
Lake Street analyst Bruce Jackson updated his model for Heron Therapeutics following the recently completed stock offering. In a research note partially titled, "Fuel Tank Filled, Ready For Lift Off," the analyst reiterates a Buy rating on Heron with a $42 price target. New Phase 3 data for HTX-011 demonstrated statistically significant reductions in pain intensity and opioid use through 72 hours post-surgery compared to placebo and the current standard of care, bupivacaine, Jackson writes. He notes that management believes the data support an opioid-sparing labeling claim for HTX-011. This would provide a significant competitive advantage, the analyst contends.
04/05/18
EVER
04/05/18
INITIATION
Target $56
EVER
Outperform
Heron Therapeutics initiated with an Outperform at Evercore ISI
Evercore ISI analyst Joshua Schimmer started Heron Therapeutics (HRTX) with an Outperform rating and $56 price target. He said that given the marked differentiation versus Pacira's (PCRX) Exparel, peak sales for Heron's HTX-011 could approach $2.5B, while Sustol/Cinvanti could add another $300M at peak. These estimates could drive a valuation potentially approaching $11B, or nearly $175 per share, in a bullish scenario, said Schimmer.

TODAY'S FREE FLY STORIES

02:45
04/24/18
04/24
02:45
04/24/18
02:45
General news
FX Update: The dollar posted fresh highs »

FX Update: The dollar…

02:05
04/24/18
04/24
02:05
04/24/18
02:05
General news
Asian Market Wrap: »

Asian Market Wrap:…

DLNG

Dynagas LNG

$9.46

-0.18 (-1.87%)

21:09
04/23/18
04/23
21:09
04/23/18
21:09
Downgrade
Dynagas LNG rating change at Wells Fargo »

Dynagas LNG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALPMY

Astellas Pharma

21:02
04/23/18
04/23
21:02
04/23/18
21:02
Hot Stocks
Astellas Pharma submits NDA for approval of Gilteritinib in AML »

Astellas Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

VZ

Verizon

$48.66

0.74 (1.54%)

, KO

Coca-Cola

$43.96

0.22 (0.50%)

20:25
04/23/18
04/23
20:25
04/23/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

VZ

Verizon

$48.66

0.74 (1.54%)

KO

Coca-Cola

$43.96

0.22 (0.50%)

MMM

3M

$216.01

-1.71 (-0.79%)

LMT

Lockheed Martin

$358.59

6.645 (1.89%)

UTX

United Technologies

$123.45

0.38 (0.31%)

CAT

Caterpillar

$153.96

0.72 (0.47%)

LLY

Eli Lilly

$80.25

1.16 (1.47%)

NEE

NextEra Energy

$161.23

0.46 (0.29%)

BIIB

Biogen

$259.30

-3.61 (-1.37%)

SHW

Sherwin-Williams

$387.51

-4.895 (-1.25%)

TRV

Travelers

$137.25

0.4 (0.29%)

FCX

Freeport McMoRan

$18.80

-0.56 (-2.89%)

PCAR

Paccar

$69.43

0.24 (0.35%)

GLW

Corning

$27.51

-0.05 (-0.18%)

FITB

Fifth Third

$31.92

0.49 (1.56%)

CNC

Centene

$110.61

-0.03 (-0.03%)

WAT

Waters

$209.48

1.23 (0.59%)

HBAN

Huntington Bancshares

$15.01

0.245 (1.66%)

QSR

Restaurant Brands

$53.50

-1.16 (-2.12%)

WAB

Wabtec

$88.07

0.53 (0.61%)

PII

Polaris Industries

$120.90

1.28 (1.07%)

HOG

Harley-Davidson

$41.00

-0.03 (-0.07%)

JBLU

JetBlue

$19.90

0.03 (0.15%)

SC

Santander Consumer

$15.71

0.03 (0.19%)

GPK

Graphic Packaging

$16.00

0.14 (0.88%)

SLCA

U.S. Silica

$27.56

-0.42 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 30

    Apr

  • 07

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 11

    May

  • 15

    May

  • 15

    May

  • 15

    May

  • 18

    May

  • 21

    May

  • 30

    May

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 13

    Jun

  • 15

    Jun

  • 24

    Jul

  • 23

    Oct

  • 14

    Dec

BOALY

Boral Ltd.

20:18
04/23/18
04/23
20:18
04/23/18
20:18
Earnings
Boral Ltd sees FY18 EBITDA contribution from property at AUD55M-AUD65M »

Sees Boral Australia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$80.25

1.16 (1.47%)

, INCY

Incyte

$68.15

-0.26 (-0.38%)

20:14
04/23/18
04/23
20:14
04/23/18
20:14
Hot Stocks
FDA recommends approval of Incyte/Eli Lilly's Baricitinib 2mg, but not 4mg in RA »

Eli Lilly (LLY) and…

LLY

Eli Lilly

$80.25

1.16 (1.47%)

INCY

Incyte

$68.15

-0.26 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 01

    May

  • 07

    May

  • 21

    May

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

VBTX

Veritex

$28.01

0.11 (0.39%)

19:35
04/23/18
04/23
19:35
04/23/18
19:35
Earnings
Veritex reports Q1 EPS 42c, consensus 40c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Sep

FSUMY

Fortescue Metal

19:15
04/23/18
04/23
19:15
04/23/18
19:15
Hot Stocks
Breaking Hot Stocks news story on Fortescue Metal  »

Fortescue Metal reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$27.70

0.1 (0.36%)

, CDNS

Cadence Design

$36.75

-0.27 (-0.73%)

19:00
04/23/18
04/23
19:00
04/23/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SANM

Sanmina

$27.70

0.1 (0.36%)

CDNS

Cadence Design

$36.75

-0.27 (-0.73%)

HLX

Helix Energy

$6.24

-0.245 (-3.78%)

TRMB

Trimble

$36.13

-0.44 (-1.20%)

RUSHA

Rush Enterprises

$43.00

-0.3 (-0.69%)

SLM

Sallie Mae

$11.68

0.015 (0.13%)

ZION

Zions Bancorp

$54.27

0.47 (0.87%)

AMP

Ameriprise

$145.45

1.74 (1.21%)

GOOG

Alphabet

$1,067.70

-5.03 (-0.47%)

ZYME

Zymeworks

$12.08

0.095 (0.79%)

TNDM

TNDM

LQ

La Quinta

$19.55

0.09 (0.46%)

BP

BP

$43.92

0.415 (0.95%)

DGICA

Donegal Group

$15.07

-0.11 (-0.72%)

AMTD

TD Ameritrade

$61.21

-0.04 (-0.07%)

WHR

Whirlpool

$150.31

0.885 (0.59%)

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

BRO

Brown & Brown

$26.56

0.6 (2.31%)

ABX

Barrick Gold

$12.93

-0.23 (-1.75%)

OI

Owens-Illinois

$21.76

0.13 (0.60%)

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

CASA

Casa Systems

$29.81

-0.35 (-1.16%)

BBBY

Bed Bath & Beyond

$17.35

0.22 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 12

    Jun

  • 26

    Apr

UAL

United Continental

$70.32

-1.405 (-1.96%)

18:45
04/23/18
04/23
18:45
04/23/18
18:45
Periodicals
United Continental CEO to forego 2017 bonus, Bloomberg reports »

United Continental CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

UAL

United Continental

$70.32

-1.405 (-1.96%)

18:37
04/23/18
04/23
18:37
04/23/18
18:37
Hot Stocks
United Continental chairman Milton will not stand for reelection »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

INFY

Infosys

$17.43

0.05 (0.29%)

18:12
04/23/18
04/23
18:12
04/23/18
18:12
Hot Stocks
Infosys sees FY18 revenue growth trending at 7.2% rate »

Comments from the Infosys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

SFNC

Simmons First National

$28.95

0.2 (0.70%)

18:04
04/23/18
04/23
18:04
04/23/18
18:04
Earnings
Simmons First National reports Q1 core EPS 57c, consensus 52c »

Reports Q1 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 14

    May

  • 24

    Sep

HLX

Helix Energy

$6.24

-0.245 (-3.78%)

18:01
04/23/18
04/23
18:01
04/23/18
18:01
Earnings
Helix Energy reports Q1 EPS (2c), consensus (6c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:50
04/23/18
04/23
17:50
04/23/18
17:50
Hot Stocks
Einhorn says Assured Guaranty has a lot of exposure to Puerto Rico »

Says Assured…

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

17:45
04/23/18
04/23
17:45
04/23/18
17:45
Hot Stocks
Tivity Health falls 19% after Q1 revenue misses estimates »

Shares of Tivity Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 12

    Jun

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

17:42
04/23/18
04/23
17:42
04/23/18
17:42
Earnings
Tivity Health affirms FY18 EPS 2.12-$2.20, consensus $2.16 »

Backs FY18 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 12

    Jun

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:42
04/23/18
04/23
17:42
04/23/18
17:42
Hot Stocks
Greenlight Capital's Einhorn says Assured Guaranty has no room for losses »

Says Assured Guaranty …

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

HD

Home Depot

$177.73

0.68 (0.38%)

, LOW

Lowe's

$84.34

0.71 (0.85%)

17:40
04/23/18
04/23
17:40
04/23/18
17:40
Initiation
Home Depot, Lowe's, Tractor Supply, O'Reilly Automotive, AutoZone, At Home Group, National Vision initiated at Wells Fargo »

Home improvement and…

HD

Home Depot

$177.73

0.68 (0.38%)

LOW

Lowe's

$84.34

0.71 (0.85%)

TSCO

Tractor Supply

$61.64

1.33 (2.21%)

ORLY

O'Reilly Automotive

$222.54

1.06 (0.48%)

AZO

AutoZone

$599.45

3.63 (0.61%)

HOME

At Home Group

$34.69

-0.305 (-0.87%)

EYE

National Vision

$31.57

-0.02 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    May

  • 12

    Jun

WBS

Webster Financial

$59.94

0.555 (0.93%)

17:37
04/23/18
04/23
17:37
04/23/18
17:37
Hot Stocks
Webster Financial increases dividend 7c to 33c »

Webster Financial, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SCHW

Charles Schwab

$55.37

0.37 (0.67%)

17:36
04/23/18
04/23
17:36
04/23/18
17:36
Hot Stocks
Charles Schwab chairman Charles Schwab sells 250K shares »

The chairman of brokerage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

NDAQ

Nasdaq

$86.92

-0.52 (-0.59%)

17:36
04/23/18
04/23
17:36
04/23/18
17:36
Periodicals
Nasdaq proposes to let companies pick where their shares trade, Reuters says »

Nasdaq said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:35
04/23/18
04/23
17:35
04/23/18
17:35
Hot Stocks
Greenlight Capital's Einhorn says short Assured Guaranty »

David Einhorn, president,…

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

SFE

Safeguard Scientifics

$12.25

-0.25 (-2.00%)

17:32
04/23/18
04/23
17:32
04/23/18
17:32
Hot Stocks
Safeguard Scientifics enters agreement with Sierra Capital »

Safeguard Scientifics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.